Summit Therapeutics Inc. (SMMT) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
8/25
Growth 2
Margin 0
Expansion 3
Platform 1
Financial 2
latest quarter score
Earnings Reports
- 8
- 10
- 24
- 9